Men and women: Cancer risk from obesity differs

men

Men and women: Cancer risk from obesity differs: A new study, co-funded by World Cancer Research Fund (WCRF), Cancer Research UK and Diabetes UK, reveals that where fat is on our body may lead to different health outcomes for men and women. The research revealed that having more body fat around your waist is more […]

Read More… from Men and women: Cancer risk from obesity differs

Wesleyan RSM trainee of the year finalist: Dr Jonathan Evans

Meet the finalist | Dr Jonathan Evans  RSM Coloproctology Section  Presentation title:  The Nrf2 inhibitor Brusatol is a potent antitumour agent, and enhances irinotecan cytotoxicity, in an orthotopic mouse model of colorectal cancer. Focus on colorectal cancer  Currently a specialist trainee in general surgery, with a sub-specialty interest in colorectal, Dr Jonathan Evans studied medicine at the University of Liverpool. […]

Read More… from Wesleyan RSM trainee of the year finalist: Dr Jonathan Evans

Avoiding a diagnosis of colon cancer

The Hippocratic Post - bowel cancer

‘One of the main risk factors for bowel cancer is genetic predisposition but it has been linked to eating too much red or cured meat. No one knows why this is the case although it may be something to do with how the gut manages that volume of protein. What we do know is that […]

Read More… from Avoiding a diagnosis of colon cancer

Colorectal cancer – from symptoms to diagnosis and treatment

The Hippocratic Post - colorectal cancer

Colorectal cancer is a general term applied to malignant tumours occurring anywhere within the colon (large bowel or large intestine). This includes the rectum which is the last part of the colon before the anus. Colorectal cancer is the second highest cause of cancer death in the in the UK (behind lung). Most cases occur […]

Read More… from Colorectal cancer – from symptoms to diagnosis and treatment